Table 1.
Characteristics of locally advanced ESCC patients
| Characteristics | ESCC patients (N = 16) |
|---|---|
| Age (years) | |
| Median (IQR) | 60.5 (56.0-67.3) |
| Mean±SD | 60.9±7.8 |
| Male, No. (%) | 14 (87.5) |
| ECOG PS, no. (%) | |
| 0 | 13 (81.3) |
| 1 | 3 (18.8) |
| Tumor location, no. (%) | |
| Proximal third | 3 (18.8) |
| Middle third | 8 (50.0) |
| Distal third | 5 (31.3) |
| Histological grade, no. (%) | |
| Well | 1 (6.3) |
| Moderate | 8 (50.0) |
| Poor | 7 (43.7) |
| Clinical T stage, no. (%) | |
| cT1 | 0 (0.0) |
| cT2 | 2 (12.5) |
| cT3 | 13 (81.3) |
| cT4 | 1 (6.3) |
| Clinical N stage, no. (%) | |
| N0 | 2 (12.5) |
| N1 | 10 (62.5) |
| N2 | 3 (18.8) |
| N3 | 1 (6.3) |
| Clinical TNM stage, no. (%) | |
| Stage I | 0 (0.0) |
| Stage II | 4 (25.0) |
| Stage III | 10 (62.5) |
| Stage IV | 2 (12.5) |
ESCC esophageal squamous cell carcinoma, IQR interquartile range, SD standard deviation, ECOG PS Eastern Cooperative Oncology Group performance status